Prelude Therapeutics saw the highest growth of 4.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 4.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Prelude Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Prelude Therapeutics has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with six publications in Q2 2024

The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 46% of filings. The World Intellectual Property Organization(WIPO), United States(US), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where Prelude Therapeutics is filings its patents..

Roche and Johnson & Johnson could be the strongest competitors for Prelude Therapeutics

Patents related to rare diseases lead Prelude Therapeutics's portfolio

Prelude Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.

Breast cancer related patents lead Prelude Therapeutics portfolio followed by ovarian cancer, and pancreatic cancer

Prelude Therapeutics has highest number of patents in breast cancer followed by ovarian cancer, pancreatic cancer, prostate cancer, and bladder carcinoma.

For comprehensive analysis of Prelude Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.